Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT02278458
Eligibility Criteria:
Inclusion Criteria:
* Locally advanced, unresectable or metastatic pancreatic cancer by histologic or cytologic confirmation without previous chemotherapy or target therapy.
* ECOG Performance Status of 0 to 1.
* Adequate organ function as defined by study-specified laboratory tests.
* Signed informed consent form.
* Willing and able to comply with study procedures.
Exclusion Criteria:
* Previous chemotherapy or target therapy.
* Currently have or have history of certain study-specified heart, liver, kidney, lung, neurological, immune or other medical conditions.
* Systemically active steroids.
* Another investigational product within 28 days prior to receiving study drug.
* Major surgery or significant traumatic injury (or unhealed surgical wounds) occurring within 28 days prior to receiving study drug.
* Infection with HIV, hepatitis B or C at screening.
* Pregnant or lactating.
* Conditions, including alcohol or drug dependence, or intercurrent illness that would affect the patient's ability to comply with study visits and procedures.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02278458
Study Brief:
Protocol Section:
NCT02278458